Product NDC: | 60258-005 |
Proprietary Name: | Cytra-K Cystrals |
Non Proprietary Name: | Potassium Citrate and Citric Acid |
Active Ingredient(s): | 1.002; 3.3 g/1; g/1 & nbsp; Potassium Citrate and Citric Acid |
Administration Route(s): | ORAL |
Dosage Form(s): | GRANULE, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60258-005 |
Labeler Name: | Cypress Pharmaceutical, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20030501 |
Package NDC: | 60258-005-01 |
Package Description: | 100 GRANULE, FOR SOLUTION in 1 BOX (60258-005-01) |
NDC Code | 60258-005-01 |
Proprietary Name | Cytra-K Cystrals |
Package Description | 100 GRANULE, FOR SOLUTION in 1 BOX (60258-005-01) |
Product NDC | 60258-005 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Potassium Citrate and Citric Acid |
Dosage Form Name | GRANULE, FOR SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20030501 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Cypress Pharmaceutical, Inc. |
Substance Name | CITRIC ACID MONOHYDRATE; POTASSIUM CITRATE |
Strength Number | 1.002; 3.3 |
Strength Unit | g/1; g/1 |
Pharmaceutical Classes | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC] |